VBL Therapeutics
Or Yehuda
About VBL Therapeutics
VBL Therapeutics is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases. VBL’s clinical pipeline is based on two distinct, proprietary platform technologies that leverage the body’s natural physiologic and genetic regulatory elements.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $58.7M
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2021)
- Ticker: nasdaq:VBLT
- Website: vblrx.com
- Phone: +97236346450
Industries & Categories
Biotechnology, Genetics, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/vbl-therapeutics-221076 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.